Elixinol Wellness Limited (ASX:EXL)

Elixinol Wellness Revenue

Elixinol Wellness had revenue of 7.20M AUD in the half year ending June 30, 2026, with 6.28% growth. This brings the company's total for the last twelve months to 15.90M, up 6.08% year-over-year. In the year 2025, Elixinol Wellness had annual revenue of 15.50M with 3.64% growth. That makes Elixinol Wellness the 36,822nd largest company in the world by revenue and 657th in Australia.

• Revenue (ttm): 15.90M
• Revenue Growth: +6.08%
• P/S Ratio: 0.18
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.90M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Australia 13.90M 89.7%
• Americas 1.59M 10.2%
• Rest of World 11.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Elixinol Wellness breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.50M	544.00K	3.64%
Dec 31, 2024	14.96M	6.69M	80.87%
Dec 31, 2023	8.27M	1.21M	17.21%
Dec 31, 2022	7.06M	-2.28M	-24.45%
Dec 31, 2021	9.34M	-5.67M	-37.79%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error